Back to URGN
ACORN CAPITAL ADVISORS, LLC → URGN
ACORN CAPITAL ADVISORS, LLC URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
4
Latest value
$67M
Q3 2026
Peak value
$67M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $33.9M |
| Q1 2026 | $30.1M |
| Q2 2026 | $61.6M |
| Q3 2026 | $67M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $67M | 1.65M | — | — |
| Q2 2026 | $61.6M | 1.67M | — | — |
| Q1 2026 | $30.1M | 1.67M | — | — |
| Q4 2025 | $33.9M | 1.45M | — | — |
Other funds holding URGN
$184.6M
$167.2M
$106.4M
$93.6M
$91.7M